Literature DB >> 25697893

Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye.

Rahul Bhargava1, Prachi Kumar2, Hemant Phogat3, Avinash Kaur3, Manjushri Kumar4.   

Abstract

PURPOSE: To assess the efficacy of dietary consumption of omega-3 fatty acids (O3FAs) on dry eye symptoms, Schirmer test, tear film break up time (TBUT) and conjunctival impression cytology (CIC) in patients with computer vision syndrome. SETTING AND
DESIGN: Interventional, randomized, double blind, multi-centric study.
METHODS: Four hundred and seventy eight symptomatic patients using computers for more than 3h per day for minimum 1 year were randomized into two groups: 220 patients received two capsules of omega-3 fatty acids each containing 180mg eicosapentaenoic acid (EPA) and 120mg docosahexaenoic acid (DHA) daily (O3FA group) and 236 patients received two capsules of a placebo containing olive oil daily for 3 months (placebo group). The primary outcome measure was improvement in dry eye symptoms and secondary outcome measures were improvement in Nelson grade and an increase in Schirmer and TBUT scores at 3 months.
RESULTS: In the placebo group, before dietary intervention, the mean symptom score, Schirmer, TBUT and CIC scores were 7.5±2, 19.9±4.7mm, 11.5±2s and 1±0.9 respectively, and 3 months later were 6.8±2.2, 20.5±4.7mm, 12±2.2s and 0.9±0.9 respectively. In the O3FA group, these values were 8.0±2.6, 20.1±4.2mm, 11.7±1.6s and 1.2±0.8 before dietary intervention and 3.9±2.2, 21.4±4mm, 15±1.7s, 0.5±0.6 after 3 months of intervention, respectively.
CONCLUSION: This study demonstrates the beneficial effect of orally administered O3FAs in alleviating dry eye symptoms, decreasing tear evaporation rate and improving Nelson grade in patients suffering from computer vision syndrome related dry eye.
Copyright © 2015 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Computer vision syndrome; Dry eye; Goblet cell density; Omega 3 fatty acids (O3FAs); Tear film break up time

Mesh:

Substances:

Year:  2015        PMID: 25697893     DOI: 10.1016/j.clae.2015.01.007

Source DB:  PubMed          Journal:  Cont Lens Anterior Eye        ISSN: 1367-0484            Impact factor:   3.077


  22 in total

1.  Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics.

Authors:  Penny A Asbell; Maureen G Maguire; Ellen Peskin; Vatinee Y Bunya; Eric J Kuklinski
Journal:  Contemp Clin Trials       Date:  2018-06-06       Impact factor: 2.226

2.  n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease.

Authors:  Penny A Asbell; Maureen G Maguire; Maxwell Pistilli; Gui-shuang Ying; Loretta B Szczotka-Flynn; David R Hardten; Meng C Lin; Roni M Shtein
Journal:  N Engl J Med       Date:  2018-04-13       Impact factor: 91.245

3.  Omega-3 supplements for dry eye.

Authors:  Joey Ton; Christina Korownyk
Journal:  Can Fam Physician       Date:  2018-11       Impact factor: 3.275

4. 

Authors:  Joey Ton; Christina Korownyk
Journal:  Can Fam Physician       Date:  2018-11       Impact factor: 3.275

5.  Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.

Authors:  Laura E Downie; Sueko M Ng; Kristina B Lindsley; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2019-12-18

6.  Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study.

Authors:  Abdullah Kaya; Yakup Aksoy
Journal:  Clin Ophthalmol       Date:  2016-05-18

7.  Oral supplementation with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: results of a prospective study.

Authors:  Jordi Gatell-Tortajada
Journal:  Clin Interv Aging       Date:  2016-05-19       Impact factor: 4.458

8.  The effect of Vaccinium uliginosum extract on tablet computer-induced asthenopia: randomized placebo-controlled study.

Authors:  Choul Yong Park; Namyi Gu; Chi-Yeon Lim; Jong-Hyun Oh; Minwook Chang; Martha Kim; Moo-Yong Rhee
Journal:  BMC Complement Altern Med       Date:  2016-08-18       Impact factor: 3.659

Review 9.  Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products.

Authors:  Victor J Drew; Ching-Li Tseng; Jerard Seghatchian; Thierry Burnouf
Journal:  Front Med (Lausanne)       Date:  2018-02-23

10.  Conjunctival impression cytology versus routine tear function tests for dry eye evaluation in contact lens wearers.

Authors:  Prachi Kumar; Rahul Bhargava; Yogesh C Arora; Sidharth Kaushal; Manjushri Kumar
Journal:  J Cytol       Date:  2015 Oct-Dec       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.